引用本文: | 许锐, 何嘉发, 邹佳晨. 阿贝西利联合内分泌治疗应用于HR+/HER2-、淋巴结阳性、高风险早期乳腺癌:评monarchE研究[J]. 循证医学, 2023, 23(2): 74-77. DOI: 10.12019/j.issn.1671-5144.2023.02.002 |
Citation: | XU Rui, HE Jia-fa, ZOU Jia-chen. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+/HER2-, Node-Positive, High-Risk, Early Breast Cancer: Review of monarchE Study[J]. Journal of Evidence-Based Medicine, 2023, 23(2): 74-77. DOI: 10.12019/j.issn.1671-5144.2023.02.002 |